Back to search
FDAFDA · Food and drugs·Recall number Z-0820-2015

CARESTREAM DIRECTVIEW CR Software Generates digital mammographic images that can be used for screening and diagnosis of breast cancer.

Published December 24, 2014 · Recall initiated: October 30, 2014

Summary

FDA records medical device Class II recall Z-0820-2015, published December 24, 2014 and initiated October 30, 2014. Recalling firm: Carestream Health, Inc.; Status: Terminated; Reported quantity: 59 units; Lot: Software Verions: 1) 5.7.312.27 , 2) 5.7.312.27, 3) 5.7.312.2031. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Reduced mammographic image quality when attempting to print true size multi-format images

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Carestream Health, Inc.
Distributor
Worldwide Distribution: US distribution to states of : NY, OH, and NC; and countries of: Argentina, Brazil, China, Chile, Colombia, France, Greece, Hong Kong, India, Japan, Korea, Mexico, Peru, Spain, Taiwan, and Thailand.
Lot
Software Verions: 1) 5.7.312.27 , 2) 5.7.312.27, 3) 5.7.312.2031
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CARESTREAM DIRECTVIEW CR Software Generates digital mammographic images that can be used for screening and diagnosis of breast cancer. recalled?

Yes. FDA published recall Z-0820-2015 on December 24, 2014. Reported hazard: Reduced mammographic image quality when attempting to print true size multi-format images

What should I do if I have this product?

Voluntary: Firm initiated · Letter